Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer’s disease (MCI and dementia) in primary care: a review and synthesis
Jerome Liss, Sheila Seleri Assunção, James J. Cummings, et al.
Journal of Internal Medicine (2021) Vol. 290, Iss. 2, pp. 310-334
Open Access | Times Cited: 172

Showing 1-25 of 172 citing articles:

2023 Alzheimer's disease facts and figures

Alzheimer s & Dementia (2023) Vol. 19, Iss. 4, pp. 1598-1695
Open Access | Times Cited: 1968
2022 Alzheimer's disease facts and figures

Alzheimer s & Dementia (2022) Vol. 18, Iss. 4, pp. 700-789
Closed Access | Times Cited: 1940
2024 Alzheimer's disease facts and figures

Alzheimer s & Dementia (2024) Vol. 20, Iss. 5, pp. 3708-3821
Open Access | Times Cited: 544
Lecanemab: Appropriate Use Recommendations
J Cummings, L Apostolova, G D Rabinovici, et al.
The Journal of Prevention of Alzheimer s Disease (2023)
Open Access | Times Cited: 350
Eye-tracking paradigms for the assessment of mild cognitive impairment: a systematic review
Alexandra Wolf, Kornkanok Tripanpitak, Satoshi Umeda, et al.
Frontiers in Psychology (2023) Vol. 14
Open Access | Times Cited: 24
Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD‐ADRD): Executive summary of recommendations for primary care
Alireza Atri, Bradford C. Dickerson, Carolyn Clevenger, et al.
Alzheimer s & Dementia (2024)
Open Access | Times Cited: 8
Cutting through the noise: A narrative review of Alzheimer's disease plasma biomarkers for routine clinical use
Michael Schöll, Agathe Vrillon, Takeshi Ikeuchi, et al.
The Journal of Prevention of Alzheimer s Disease (2025), pp. 100056-100056
Open Access | Times Cited: 1
Determinants of dementia diagnosis in U.S. primary care in the past decade: A scoping review
Chelsea G. Cox, Barbara L. Brush, Lindsay C. Kobayashi, et al.
The Journal of Prevention of Alzheimer s Disease (2025) Vol. 12, Iss. 2, pp. 100035-100035
Open Access | Times Cited: 1
Brain health clinics – An evolving clinical pathway?
Anneka F Butters, Jonathan Blackman, Hannah Farouk, et al.
The Journal of Prevention of Alzheimer s Disease (2025), pp. 100051-100051
Open Access | Times Cited: 1
Plasma microglial-derived extracellular vesicles are increased in frail patients with Mild Cognitive Impairment and exert a neurotoxic effect
Caterina Visconte, Maria Teresa Golia, Chiara Fenoglio, et al.
GeroScience (2023) Vol. 45, Iss. 3, pp. 1557-1571
Open Access | Times Cited: 21
MicroRNAs and MAPKs: Evidence of These Molecular Interactions in Alzheimer’s Disease
Ivana Raffaele, Serena Silvestro, Emanuela Mazzon
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4736-4736
Open Access | Times Cited: 20
The common marmoset as a model of neurodegeneration
Claudia Pérez-Cruz, Juan D. Rodríguez-Callejas
Trends in Neurosciences (2023) Vol. 46, Iss. 5, pp. 394-409
Closed Access | Times Cited: 19
Altered Extracellular Vesicle miRNA Profile in Prodromal Alzheimer’s Disease
Caterina Visconte, Chiara Fenoglio, María Serpente, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14749-14749
Open Access | Times Cited: 18
Adapting prescribing criteria for amyloid‐targeted antibodies for adults with Down syndrome
Hampus Hillerstrom, Richard A. Fisher, Matthew P. Janicki, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 5, pp. 3649-3656
Open Access | Times Cited: 7
Retinal imaging biomarkers of Alzheimer's disease: A systematic review and meta‐analysis of studies using brain amyloid beta status for case definition
Gizem Ashraf, Myra B. McGuinness, Muhammad Azaan Khan, et al.
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring (2023) Vol. 15, Iss. 2
Open Access | Times Cited: 14
People get ready! A new generation of Alzheimer's therapies may require new ways to deliver and pay for healthcare
Karin Wahlberg, Bengt Winblad, Amanda Cole, et al.
Journal of Internal Medicine (2023) Vol. 295, Iss. 3, pp. 281-291
Open Access | Times Cited: 14
Remote Self-Administration of Cognitive Screeners for Older Adults Prior to a Primary Care Visit: Pilot Cross-Sectional Study of the Reliability and Usability of the MyCog Mobile Screening App
Stephanie Ruth Young, Elizabeth M. Dworak, Greg Joseph Byrne, et al.
JMIR Formative Research (2024) Vol. 8, pp. e54299-e54299
Open Access | Times Cited: 5
For a dementia diagnosis, clinical acumen must precede biomarkers
David S. Knopman
The Lancet Neurology (2024) Vol. 23, Iss. 3, pp. 225-226
Closed Access | Times Cited: 5
Monoclonal antibodies for treating early Alzheimer disease—a commentary on recent ‘positive’ trials
Ian Scott
Age and Ageing (2024) Vol. 53, Iss. 2
Closed Access | Times Cited: 5
Optimising Alzheimer’s Disease Diagnosis and Treatment: Assessing Cost-Utility of Integrating Blood Biomarkers in Clinical Practice for Disease-Modifying Treatment
Sandar Aye, Ron Handels, Bengt Winblad, et al.
The Journal of Prevention of Alzheimer s Disease (2024)
Open Access | Times Cited: 5
Heavy metal exposure and metabolomics analysis: an emerging frontier in environmental health
Kainat Ilyas, Hajra Iqbal, Muhammad Sajid Hamid Akash, et al.
Environmental Science and Pollution Research (2024) Vol. 31, Iss. 26, pp. 37963-37987
Closed Access | Times Cited: 5
The Validity of a Smartphone-Based Application for Assessing Cognitive Function in the Elderly
Jin‐Young Min, Duri Kim, Ha Nee Jang, et al.
Diagnostics (2025) Vol. 15, Iss. 1, pp. 92-92
Open Access
Computerized cognitive testing to capture cognitive decline in Alzheimer's disease: Longitudinal findings from the ARMADA study
Roos J. Jutten, Emily Ho, Tatiana Karpouzian‐Rogers, et al.
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring (2025) Vol. 17, Iss. 1
Open Access
Developing multifactorial dementia prediction models using clinical variables from cohorts in the US and Australia
Caitlin A. Finney, David A. Brown, Artur Shvetcov
Translational Psychiatry (2025) Vol. 15, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top